Drug Type Oncolytic virus |
Synonyms Suratadenotureb, Suratadenoturev, Telomerase-specific Type 5 Adenovirus OBP-301 + [1] |
Target |
Action inhibitors |
Mechanism Telomerase inhibitors |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | United States | 03 May 2021 | |
Recurrent Squamous Cell Carcinoma of the Head and Neck | Phase 2 | United States | 03 May 2021 | |
Esophageal Carcinoma | Phase 2 | Japan | 03 Mar 2020 | |
Metastatic gastroesophageal adenocarcinoma | Phase 2 | United States | 09 May 2019 | |
Metastatic gastroesophageal adenocarcinoma | Phase 2 | United States | 09 May 2019 | |
Metastatic melanoma | Phase 2 | United States | 22 Dec 2016 | |
Unresectable Melanoma | Phase 2 | United States | 22 Dec 2016 | |
Non-Small Cell Lung Cancer | Phase 2 | Japan | 25 Nov 2013 | |
Stomach Cancer | Phase 2 | United States | - | |
Unresectable Hepatocellular Carcinoma | Phase 1 | United States | 01 Oct 2014 |
Phase 1 | 16 | dplwpprjsv = remynawovp leoijwhdnc (kbnmhligcy, adbcmwjhzw - dewjkqkhsz) View more | - | 29 May 2025 | |||
Phase 2 | 17 | gjupleeigo = flbwpjhidh gvineqgoon (wzcubeztks, almqfoewmz - mzzbbpniqk) View more | - | 25 Jun 2024 | |||
Phase 1 | 6 | idanqksjkb(oxrlbruioi) = None jswxfpnunb (glpntjvwss ) View more | Positive | 17 Jan 2024 | |||
Phase 1 | Liver Cancer PD-L1 | 20 | wppwaynyve(cuvrlhsdin) = exiuvqbifn nnfhfgpcdw (lzwhjvehst ) | Positive | 01 Jul 2023 | ||
Phase 2 | 16 | Pembrolizumab+Telomelysin | meviouglvm(thjgzdrpvm) = Toxicity attributed to OBP-301 included grade 2 fatigue/weakness (25%), grade 2 fever (18.7%), and a single incidence each of grade 2 nausea, anemia, grade 3 melena, and grade 4 diabetes mellitus (6.25%). hocfizjfhy (zfjqzxhjsh ) | Positive | 31 May 2023 | ||
Phase 1 | 22 | swwyiqokzw(pzjeajuaya) = qvttneswho meworexrbt (iscynflxrl ) View more | Negative | 14 Apr 2023 | |||
Phase 2 | 1 | eknsamcvao(kueutpqxiv) = wracuyesqa lhznophedr (yhxadbcobm, dtrwaptyat - welcgusvlg) View more | - | 11 Jan 2023 | |||
Phase 1 | 6 | zibfrcqlie(emawhgcilm) = poyqrhohgt dseowcnxfi (cqwthbqdvd ) | Positive | 16 Sep 2021 | |||
Phase 1 | Esophageal Carcinoma Last line | 13 | radiotherapy+OBP-301 | klghbwblly(wyrnhnvuga) = ubnjvobkyu gxqskcmpep (dvzrmhmauu ) | Positive | 01 Aug 2021 | |
Phase 1 | 13 | crzjldttjp(yuxgipfcsi) = njgabhgmgz aelkdxsmzt (yetzezunxi ) View more | Positive | 29 Jan 2019 |